Population
1 adult male (47 years old) with acute hepatitis who developed fulminant myocarditis
Design
Case_report
Follow-up
Approximately 1 month (from admission to death)
Authors
Loading...
May link steroid immunosuppression in hepatitis to HHV-6 myocarditis exacerbation; hypothesis-generating and requires prospective validation.
This case highlights the potential risk of fatal fulminant myocarditis exacerbation due to HHV-6 reactivation following immunosuppressive steroid therapy for acute hepatitis.
Fukae et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: